ORLISTAT Side Effects

6935721-X | Arthralgia
on Aug 09, 2010 Male patient from UNITED KINGDOM , 54 years of age, was diagnosed with overweight, blood testosterone decreased and was treated with Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia. Orlistat dosage: Daily Dose: 360 Milligram(s). During the same period patient was treated with TESTOSTERONE (View Testosterone Review and Testosterone Label ).

6916689-9 | Monarthritis, Renal Failure Acute
Patient was taking Orlistat (View Usage). Patient had the following side effects: monarthritis, renal failure acute on Jul 26, 2010 from ISRAEL Additional patient health information: Female patient , 60 years of age, weighting 114.6 lb, was diagnosed with weight control (What is weight control?), arthritis (What is arthritis?) and. Orlistat dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), ETORICOXIB (View Etoricoxib Review and Etoricoxib Label ).

6898647-6 | Abdominal Pain, Acute Hepatic Failure, Antinuclear Antibody Positive, Asthenia, Cholestasis, Fatigue, Hepatic Necrosis, Influenza Like Illness
Adverse event was reported on Jul 23, 2010 by a Female patient taking Orlistat (View Usage) (Dosage: / Oral) . Location: UNITED STATES , 40 years of age, After Orlistat was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), acute hepatic failure, antinuclear antibody positive, asthenia, cholestasis, fatigue, hepatic necrosis, influenza like illness.

6859954-6 | Arthralgia
on Jul 09, 2010 Male patient from UNITED KINGDOM , 54 years of age, was diagnosed with overweight, blood testosterone decreased and was treated with Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia. Orlistat dosage: Daily Dose: 360 Milligram(s). During the same period patient was treated with TESTOSTERONE (View Testosterone Review and Testosterone Label ).


6848349-7 | Diarrhoea, Rectal Haemorrhage
on Jul 09, 2010 Male patient from UNITED KINGDOM , 20 years of age, weighting 249.1 lb, was diagnosed with weight control (What is weight control?) and was treated with Orlistat (View Usage). Patient had the following side effects: diarrhoea, rectal haemorrhage. Orlistat dosage: .

6839945-1 | Diarrhoea, Rectal Haemorrhage
Patient was taking Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: diarrhoea, rectal haemorrhage on Jul 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 20 years of age, weighting 249.1 lb, was diagnosed with weight control (What is weight control?) and. Orlistat dosage: 120mg Per Day.

6819977-X | Diarrhoea, Rectal Haemorrhage
Adverse event was reported on Jun 25, 2010 by a Male patient taking Orlistat (View Usage) (Dosage: ) was diagnosed with weight control (What is weight control?) and. Location: UNITED KINGDOM , 20 years of age, weighting 249.1 lb, Patient experienced the following unwanted or unexpected effects: diarrhoea, rectal haemorrhage.

6801259-3 | Diarrhoea, Rectal Haemorrhage
on Jun 25, 2010 Male patient from UNITED KINGDOM , 20 years of age, weighting 249.1 lb, was treated with Orlistat (View Usage). Patient had the following side effects: diarrhoea, rectal haemorrhage. Orlistat dosage: 120mg Per Day.

6796162-1 | Nephrolithiasis
on Jun 17, 2010 Female patient from UNITED KINGDOM , 57 years of age, weighting 266.8 lb, was diagnosed with hypertension and was treated with Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: nephrolithiasis. Orlistat dosage: . During the same period patient was treated with AMPICILLIN SODIUM/SULBACTAM SODIUM (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ), REDUCTIL (View Reductil Review and Reductil Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ).

6790734-6 | Alanine Aminotransferase Increased
Patient was taking Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased on Jun 22, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 27 years of age, was diagnosed with psoriasis and. Orlistat dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6763006-3 | External Ear Cellulitis, Liver Function Test Abnormal
Adverse event was reported on Jun 08, 2010 by a Female patient taking Orlistat (View Usage) (Dosage: 1 Capsule Tid With Meals Po) was diagnosed with weight control (What is weight control?), blood cholesterol and. Location: UNITED STATES , 56 years of age, weighting 224.4 lb, Patient had the following side effects: external ear cellulitis, liver function test abnormal. During the same period patient was treated with SIMVASTATIN (1/2 Tablet Once Daily Po) (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TRASODONE` (View Trasodone` Review and Trasodone` Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), TRAMADOL (View Tramadol Review and Tramadol Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), FLONASE (View Flonase Review and Flonase Label ).

6733875-1 | Abdominal Distension, Abdominal Pain, Abdominal Pain Upper, Abdominal Tenderness, Nausea, Oedema, Pancreatitis Acute
on May 17, 2010 Female patient from UNITED KINGDOM , 53 years of age, was treated with Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), abdominal pain upper, abdominal tenderness, nausea (What is nausea?), oedema, pancreatitis acute. Orlistat dosage: . During the same period patient was treated with SITAGLIPTIN PHOSPHATE (View Sitagliptin Phosphate Review and Sitagliptin Phosphate Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6724109-2 | Rectal Discharge, Rectal Haemorrhage
on May 06, 2010 Female patient from UNITED KINGDOM , 52 years of age, weighting 213.8 lb, was diagnosed with oesophagitis, dizziness (What is dizziness?), hyperlipidaemia and was treated with Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: rectal discharge, rectal haemorrhage. Orlistat dosage: . During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ), PIZOTIFEN (View Pizotifen Review and Pizotifen Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6723915-8 | Acute Coronary Syndrome, Acute Myocardial Infarction, Atrial Fibrillation, Cough, Dysuria, Intermittent Claudication, Joint Swelling, Lower Respiratory Tract Infection
Patient was taking Orlistat (View Usage). Patient had the following side effects: acute coronary syndrome, acute myocardial infarction, atrial fibrillation (What is atrial fibrillation?), cough, dysuria, intermittent claudication, joint swelling, lower respiratory tract infection on Mar 05, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 71 years of age, weighting 220.5 lb, was diagnosed with obesity (What is obesity?), hypertension, gastric disorder and. Orlistat dosage: . During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MEBEVERINE HYDROCHLORIDE (View Mebeverine Hydrochloride Review and Mebeverine Hydrochloride Label ).

6711689-6 | Rectal Haemorrhage
Adverse event was reported on Apr 27, 2010 by a Female patient taking Orlistat (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?) and. Location: UNITED KINGDOM , child 3 years of age, weighting 59.52 lb, After Orlistat was administered, patient had the following side effects: rectal haemorrhage.

6709086-2 | Pancreatitis Acute
on Apr 15, 2010 Female patient from , 53 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Orlistat dosage: 360 Mg / Per Day /. During the same period patient was treated with SITAGLIPTIN PHOSPHATE TABLET (SITAGLIPTIN PHOSPHATE) (100 Mg / Per Day / Oral) (View Sitagliptin Phosphate Tablet (sitagliptin Phosphate) Review and Sitagliptin Phosphate Tablet (sitagliptin Phosphate) Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6691992-9 | Pancreatitis Acute
on Apr 15, 2010 Female patient from UNITED KINGDOM , 53 years of age, was treated with Orlistat (View Usage). Patient had the following side effects: pancreatitis acute. Orlistat dosage: . During the same period patient was treated with JANUVIA (View Januvia Review and Januvia Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6655820-X | Influenza Like Illness, Pneumonia
Patient was taking Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: influenza like illness, pneumonia (What is pneumonia?) on Mar 19, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 56 years of age, was diagnosed with obesity (What is obesity?) and. Orlistat dosage: . During the same period patient was treated with CITALOPRAM (View Citalopram Review and Citalopram Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6618172-7 | Faeces Pale
Adverse event was reported on Feb 26, 2010 by a Female patient taking Orlistat (View Usage) (Dosage: ) was diagnosed with osteoporosis (What is osteoporosis?), gastritis, anxiety (What is anxiety?), ill-defined disorder, flatulence and. Location: URUGUAY , weighting 146.8 lb, Patient experienced the following unwanted or unexpected effects: faeces pale. During the same period patient was treated with CALCIUM CASEINATE (View Calcium Caseinate Review and Calcium Caseinate Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), OMEPRAZOL (View Omeprazol Review and Omeprazol Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), SIMETICONE (View Simeticone Review and Simeticone Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ).

6585068-9 | Abdominal Pain Upper, Abdominal Tenderness, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Blood Alkaline Phosphatase Increased, Blood Amylase Increased, Blood Glucose Increased, Nausea
on Feb 05, 2010 Female patient from UNITED KINGDOM , 73 years of age, was diagnosed with obesity (What is obesity?) and was treated with Orlistat (View Usage). Patient had the following side effects: abdominal pain upper, abdominal tenderness, alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), blood alkaline phosphatase increased, blood amylase increased, blood glucose increased, nausea (What is nausea?). Orlistat dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6568367-6 | Abdominal Pain Upper, Abdominal Tenderness, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Amylase Increased, Blood Glucose Increased, C-reactive Protein Increased, Nausea, Pancreatic Enzymes Increased
on Jan 25, 2010 Female patient from UNITED KINGDOM , 45 years of age, was diagnosed with obesity (What is obesity?) and was treated with Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: abdominal pain upper, abdominal tenderness, alanine aminotransferase increased, aspartate aminotransferase increased, blood amylase increased, blood glucose increased, c-reactive protein increased, nausea (What is nausea?), pancreatic enzymes increased. Orlistat dosage: . During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ), THIAMINE (View Thiamine Review and Thiamine Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ), LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ). Patient was hospitalized.

6568365-2 | Abdominal Pain Upper, Abdominal Tenderness, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Blood Alkaline Phosphatase Increased, Blood Amylase Increased, Blood Glucose Increased, Nausea
Patient was taking Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, abdominal tenderness, alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), blood alkaline phosphatase increased, blood amylase increased, blood glucose increased, nausea (What is nausea?) on Jan 25, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 73 years of age, was diagnosed with obesity (What is obesity?) and. Orlistat dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

6537213-9 | Blepharitis, Keratitis, Photophobia
Adverse event was reported on Jan 06, 2010 by a Female patient taking Orlistat (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?), multiple allergies, hypertension and. Location: UNITED KINGDOM , 68 years of age, weighting 176.4 lb, Patient had the following side effects: blepharitis, keratitis, photophobia. During the same period patient was treated with CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), DULOXETINE (View Duloxetine Review and Duloxetine Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6534638-2 | Blood Thyroid Stimulating Hormone Increased, Laboratory Test Abnormal, Thyroid Function Test Abnormal, Thyroxine Free Decreased
on Jan 07, 2010 Male patient from UNITED KINGDOM , 49 years of age, weighting 255.7 lb, was diagnosed with hepatic steatosis and was treated with Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: blood thyroid stimulating hormone increased, laboratory test abnormal, thyroid function test abnormal, thyroxine free decreased. Orlistat dosage: . During the same period patient was treated with FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), CETIRIZINE HYDROCHLORIDE (View Cetirizine Hydrochloride Review and Cetirizine Hydrochloride Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), BETAMETHASONE VALERATE (View Betamethasone Valerate Review and Betamethasone Valerate Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ).

6534005-1 | Blood Thyroid Stimulating Hormone Increased, Laboratory Test Abnormal, Thyroid Function Test Abnormal, Thyroxine Decreased
on Jan 07, 2010 Male patient from UNITED KINGDOM , 49 years of age, weighting 255.7 lb, was treated with Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: blood thyroid stimulating hormone increased, laboratory test abnormal, thyroid function test abnormal, thyroxine decreased. Orlistat dosage: . During the same period patient was treated with BETAMETHASONE VALERATE (View Betamethasone Valerate Review and Betamethasone Valerate Label ), CETIRIZINE HYDROCHLORIDE (View Cetirizine Hydrochloride Review and Cetirizine Hydrochloride Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ).

6533373-4 | Blepharitis, Keratitis, Photophobia
Patient was taking Orlistat (View Usage). Patient had the following side effects: blepharitis, keratitis, photophobia on Jan 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 68 years of age, weighting 176.4 lb, was diagnosed with obesity (What is obesity?), multiple allergies, stress urinary incontinence, hypertension and. Orlistat dosage: 360mg Per Day. During the same period patient was treated with CETIRIZINE (View Cetirizine Review and Cetirizine Label ), DULOXETINE (View Duloxetine Review and Duloxetine Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6532574-9 | Cerebrovascular Accident, Transient Ischaemic Attack
Adverse event was reported on Jan 07, 2010 by a Female patient taking Orlistat (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED KINGDOM , weighting 240.3 lb, After Orlistat was administered, patient had the following side effects: cerebrovascular accident, transient ischaemic attack. During the same period patient was treated with AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), QUININE SULPHATE (View Quinine Sulphate Review and Quinine Sulphate Label ), RIMONABANT (View Rimonabant Review and Rimonabant Label ).

6504920-3 | Acute Coronary Syndrome, Acute Myocardial Infarction, Atrial Fibrillation, Cough, Dysuria, Intermittent Claudication, Joint Swelling, Lower Respiratory Tract Infection
on Dec 10, 2009 Female patient from UNITED KINGDOM , 71 years of age, weighting 220.5 lb, was diagnosed with obesity (What is obesity?), hypertension, gastric disorder and was treated with Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, acute myocardial infarction, atrial fibrillation (What is atrial fibrillation?), cough, dysuria, intermittent claudication, joint swelling, lower respiratory tract infection. Orlistat dosage: . During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ), GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MEBEVERINE HYDROCHLORIDE (View Mebeverine Hydrochloride Review and Mebeverine Hydrochloride Label ).

6466896-7 | Asthenopia, Diarrhoea, Hypoaesthesia Facial, Hypotension, Renal Failure
on Dec 02, 2009 Female patient from UNITED KINGDOM , 35 years of age, weighting 253.3 lb, was diagnosed with asthma (What is asthma?), contraception and was treated with Orlistat (View Usage). Patient had the following side effects: asthenopia, diarrhoea, hypoaesthesia facial, hypotension, renal failure. Orlistat dosage: 360mg Per Day. During the same period patient was treated with ALBUTEROL SULFATE AUTOHALER (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), NOVOMIX (136iu Per Day) (View Novomix Review and Novomix Label ), DEPO PROVERA (View Depo-provera Review and Depo-provera Label ). Patient was hospitalized.

6466185-0 | Asthenopia, Diarrhoea, Hypoaesthesia Facial, Hypotension, Renal Failure
Patient was taking Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: asthenopia, diarrhoea, hypoaesthesia facial, hypotension, renal failure on Nov 24, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 35 years of age, weighting 253.3 lb, was diagnosed with weight control (What is weight control?), asthma (What is asthma?), contraception and. Orlistat dosage: . During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), DEPO PROVERA (View Depo-provera Review and Depo-provera Label ), NOVOMIX (View Novomix Review and Novomix Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ALBUTEROL SULFATE AUTOHALER (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ). Patient was hospitalized.

6464175-5 | Abdominal Pain, Asthenia, Circulatory Collapse, Depressed Level Of Consciousness, Diarrhoea, Dizziness, Dysarthria
Adverse event was reported on Nov 16, 2009 by a Female patient taking Orlistat (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?), abdominal pain upper and. Location: UNITED KINGDOM , 59 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), asthenia, circulatory collapse, depressed level of consciousness, diarrhoea, dizziness (What is dizziness?), dysarthria. During the same period patient was treated with METFORMIN HCL (Also Reported That Patient Received 500mg Three Times A Day For The Past Eight Years.) (View Metformin Hcl Review and Metformin Hcl Label ), TAGAMET (Strength: 200mg/2ml.) (View Tagamet Review and Tagamet Label ), CO AMILOFRUSE (View Co-amilofruse Review and Co-amilofruse Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SODIUM BICARBONATE IN PLASTIC CONTAINER (View Sodium Bicarbonate In Plastic Container Review and Sodium Bicarbonate In Plastic Container Label ). Patient was hospitalized.

6415621-4 | Chronic Obstructive Pulmonary Disease, Mechanical Ventilation, Respiratory Failure
on Oct 13, 2009 Male patient from UNITED KINGDOM , 55 years of age, weighting 286.6 lb, was diagnosed with obesity (What is obesity?), schizophrenia, hypertension, depression (What is depression?), blood cholesterol increased and was treated with Orlistat (View Usage). Patient had the following side effects: chronic obstructive pulmonary disease, mechanical ventilation, respiratory failure. Orlistat dosage: . During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), AMISULPRIDE (View Amisulpride Review and Amisulpride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6405476-6 | Chronic Obstructive Pulmonary Disease, Mechanical Ventilation, Respiratory Failure
on Oct 12, 2009 Male patient from UNITED KINGDOM , 55 years of age, weighting 286.6 lb, was diagnosed with obesity (What is obesity?), schizophrenia, hypertension, depression (What is depression?), blood cholesterol increased and was treated with Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: chronic obstructive pulmonary disease, mechanical ventilation, respiratory failure. Orlistat dosage: . During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMISULPRIDE (View Amisulpride Review and Amisulpride Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6329329-7 | Dehydration, Diarrhoea, Renal Failure Acute
Patient was taking Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, renal failure acute on Aug 19, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 58 years of age, weighting 440.9 lb, was diagnosed with overweight and. Orlistat dosage: . During the same period patient was treated with AMISULPRIDE (View Amisulpride Review and Amisulpride Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized and became disabled.

6329328-5 | Abdominal Pain, Cholelithiasis
Adverse event was reported on Aug 20, 2009 by a Female patient taking Orlistat (View Usage) (Dosage: 240mg Per Day) was diagnosed with obesity (What is obesity?), hypertension and. Location: UNITED KINGDOM , 62 years of age, weighting 200.6 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), cholelithiasis. During the same period patient was treated with AMLODIPINE (5mg Per Day) (View Amlodipine Review and Amlodipine Label ), BENDROFLUMETHIAZIDE (2.5mg Per Day) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), RAMIPRIL (1.25g Per Day) (View Ramipril Review and Ramipril Label ).

6326816-2 | Dehydration, Diarrhoea, Renal Failure Acute
on Aug 19, 2009 Female patient from UNITED KINGDOM , 58 years of age, weighting 440.9 lb, was diagnosed with overweight and was treated with Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: dehydration, diarrhoea, renal failure acute. Orlistat dosage: . During the same period patient was treated with AMISULPRIDE (View Amisulpride Review and Amisulpride Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ). Patient was hospitalized and became disabled.

6312328-9 | Demyelination
on Jul 31, 2009 Female patient from UNITED KINGDOM , 38 years of age, was treated with Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: demyelination. Orlistat dosage: .

6312327-7 | Retinal Vein Thrombosis
Patient was taking Orlistat (View Usage). Patient had the following side effects: retinal vein thrombosis on Jul 31, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 72 years of age, . Orlistat dosage: .

6284897-9 | Thrombocytopenia
Adverse event was reported on Jul 17, 2009 by a Female patient taking Orlistat (View Usage) (Dosage: 360mg Per Day) was diagnosed with obesity (What is obesity?) and. Location: UNITED KINGDOM , 58 years of age, weighting 200.6 lb, After Orlistat was administered, patient had the following side effects: thrombocytopenia. Patient was hospitalized.

6284390-3 | Dyschezia, Polyp
on Jul 17, 2009 Male patient from BRAZIL , weighting 209.4 lb, was diagnosed with weight control (What is weight control?), hypertension and was treated with Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: dyschezia, polyp. Orlistat dosage: Frequency: Every Day After Lunch And When ^he Eats A Lot^.. During the same period patient was treated with ARADOIS (View Aradois Review and Aradois Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), GLIFAGE (View Glifage Review and Glifage Label ).

6279182-5 | Thrombocytopenia
on Jul 17, 2009 Female patient from UNITED KINGDOM , 58 years of age, weighting 200.6 lb, was diagnosed with obesity (What is obesity?) and was treated with Orlistat (View Usage). Patient had the following side effects: thrombocytopenia. Orlistat dosage: . Patient was hospitalized.

6276301-1 | Hypothyroidism
Patient was taking Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: hypothyroidism on Jul 16, 2009 from UNITED KINGDOM Additional patient health information: Female patient , weighting 275.6 lb, was diagnosed with obesity (What is obesity?), polycystic ovaries and. Orlistat dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CERAZETTE (View Cerazette Review and Cerazette Label ).

6265777-1 | Grand Mal Convulsion
Adverse event was reported on Jul 03, 2009 by a Female patient taking Orlistat (View Usage) (Dosage: 180mg Per Day) . Location: UNITED KINGDOM , 42 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: grand mal convulsion.

6261336-5 | Grand Mal Convulsion
on Jul 03, 2009 Female patient from UNITED KINGDOM , 42 years of age, weighting 176.4 lb, was diagnosed with weight control (What is weight control?) and was treated with Orlistat (View Usage). Patient had the following side effects: grand mal convulsion. Orlistat dosage: .

6261272-4 | Appendicitis, Impaired Healing, Umbilical Hernia
on Jun 29, 2009 Female patient from UNITED KINGDOM , weighting 249.1 lb, was diagnosed with obesity (What is obesity?), depression (What is depression?) and was treated with Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: appendicitis (What is appendicitis?), impaired healing, umbilical hernia. Orlistat dosage: . During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6256358-4 | Dyschezia, Polyp
Patient was taking Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: dyschezia, polyp on Jun 26, 2009 from BRAZIL Additional patient health information: Male patient , weighting 209.4 lb, was diagnosed with weight control (What is weight control?), hypertension and. Orlistat dosage: Frequency: Every Day After Lunch And When ^he Eats A Lot^.. During the same period patient was treated with ARADOIS (View Aradois Review and Aradois Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), GLIFAGE (View Glifage Review and Glifage Label ).

6256355-9 | Diarrhoea, Diverticulitis
Adverse event was reported on Jun 22, 2009 by a Female patient taking Orlistat (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?), blood pressure (What is blood pressure?), irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED KINGDOM , weighting 183.2 lb, Patient had the following side effects: diarrhoea, diverticulitis. During the same period patient was treated with IRBESARTAN (View Irbesartan Review and Irbesartan Label ), PREMARIN (Reported As Premaran) (View Premarin Review and Premarin Label ), LORATADINE (View Loratadine Review and Loratadine Label ), FIBER NOS (Reported As Fibrogel 1 Sachet Daily) (View Fiber Nos Review and Fiber Nos Label ).

6254022-9 | Hypothyroidism
on Jun 23, 2009 Female patient from UNITED KINGDOM , weighting 233.9 lb, was diagnosed with obesity (What is obesity?), pain (What is pain?), depression (What is depression?) and was treated with Orlistat (View Usage). After Orlistat was administered, patient had the following side effects: hypothyroidism. Orlistat dosage: . During the same period patient was treated with PERGALEN (Reported As Pergablin 2 Taken Daily) (View Pergalen Review and Pergalen Label ), FLUOXETINE HCL (Reported As One Taken Daily.) (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), NAFTIDROFURYL (Reported As Naftidrofurl Three Taken Daily.) (View Naftidrofuryl Review and Naftidrofuryl Label ).

6250532-9 | Diverticular Perforation, Diverticulum
on Jun 25, 2009 Female patient from UNITED KINGDOM , 46 years of age, weighting 181.9 lb, was diagnosed with obesity (What is obesity?) and was treated with Orlistat (View Usage). Patient experienced the following unwanted or unexpected effects: diverticular perforation, diverticulum. Orlistat dosage: . Patient was hospitalized and became disabled.

6250494-4 | Cardiac Arrest, Nephropathy, Normochromic Normocytic Anaemia
Patient was taking Orlistat (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), nephropathy, normochromic normocytic anaemia on Jun 23, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 66 years of age, was diagnosed with weight control (What is weight control?) and. Orlistat dosage: . During the same period patient was treated with INSULIN ASPART (View Insulin Aspart Review and Insulin Aspart Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), FUROSEMIDE INTENSOL (View Furosemide Intensol Review and Furosemide Intensol Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ).